Sox2 promotes tamoxifen resistance in breast cancer cells. - sprookjes - yvandenbroek - TriplyDB

Sox2 promotes tamoxifen resistance in breast cancer cells.

Sox2 promotes tamoxifen resistance in breast cancer cells.

http://www.wikidata.org/entity/Q34381786

about

Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication A Role for Notch Signalling in Breast Cancer and Endocrine Resistance The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer Steroid hormones, steroid receptors, and breast cancer stem cells Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.Stratification and therapeutic potential of PML in metastatic breast cancer CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistance Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer Disruption of the ER-α36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cells SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells.A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence Oncogenesis and induced pluripotency - commonalities of signalling pathways Downregulation of ER-α36 expression sensitizes HER2 overexpressing breast cancer cells to tamoxifen Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors The role of Nanog expression in tamoxifen-resistant breast cancer cells Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.Clinicopathological significance of Sox2 expression in patients with breast cancer: a meta-analysis.Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype.Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer The converging roles of BRD4 and gene transcription in pluripotency and oncogenesis Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA construct HIF-1-alpha links mitochondrial perturbation to the dynamic acquisition of breast cancer tumorigenicity.SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells.Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.SOX2 and cancer: current research and its implications in the clinic Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.Laminin Modulates the Stem Cell Population in LM05-E Murine Breast Cancer Cells Through the Activation of the MAPK/ERK Pathway.Induced Expression of Cancer Stem Cell Markers ALDH1A3 and Sox-2 in Hierarchical Reconstitution of Apoptosis-resistant Human Breast Cancer Cells.The dark side of SOX2: cancer - a comprehensive overview.mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.Sox2: regulation of expression and contribution to brain tumors.Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.

P2860

Q26745972-EB3AB472-38AD-4A20-BA27-ADD2042A44A6 Q26765912-53C79360-AAA4-4D6C-B7F0-95882EE4B66F Q26785448-78D01901-D38E-476C-A709-4C5A5991C076 Q26799113-A7244E01-C007-4B6F-ABE0-1A7C3F13511E Q27342050-8EF64D80-D5B3-4F45-A72B-8A892894E6A5 Q28387589-9627B897-CF98-4809-BC17-83006A231E55 Q28540790-11853A04-B0AB-4A01-8081-14C29AE42828 Q33653485-DDE70EA6-F199-4649-B835-4FDAD9284D0B Q33721249-5EAF0397-013E-4D66-9D71-FBCC0BA2AAA9 Q33875325-C3DCAD60-C98F-4F92-8CE3-6FD167536D61 Q34156192-29C527AD-99BC-4BD4-9738-CDC68E38D045 Q34269756-42244145-CD00-4E0E-A5C0-22B3F3557489 Q34483490-5CA8111C-9E58-438F-8BD5-0E39EAF49288 Q34654576-4EDA520C-26A5-4AF4-9863-76D6B74E8845 Q35066337-29FCF35F-0E4A-4124-B707-D01481FF0ED6 Q35402408-9E22F716-4315-4C0D-80FD-2929E0D97953 Q35545648-CF4B5248-087C-4254-94DA-19ADE4861B1C Q35703398-FDD9C188-83F5-4CDC-9B88-ACA4816413A9 Q35709636-50506ED1-26F5-467C-9632-DEE3B8D7A123 Q35925768-DC5418E4-2A9F-4F86-9058-22FC0B7D59A8 Q35989767-4D8D45B1-593E-473A-BF1B-ECABE836A1AE Q36030226-87E9F700-D9DF-4A6A-ADF4-52D02E9D1841 Q36081650-66B9B36D-95F9-4586-BD55-4EE007FEDFA9 Q36123897-9786F658-0236-4CEF-A259-9A358223DB0A Q36287107-306B14AB-F4EC-4CA7-A84B-B59EED99B683 Q36544675-509B3E70-A2CF-4146-8897-B4F87592BB1F Q37059663-5A4E8585-B4B7-4915-B305-787CD0CFB821 Q37376195-05EE53DC-0BC7-440D-9D3D-05A936B32DA7 Q37697914-4B320934-7BF2-4886-848D-051FF95F9AB2 Q37699344-9706FC93-77A7-42D6-86B7-B54DCC832DA8 Q37701609-E8A6C081-F373-4DA8-BDD4-F6B418085027 Q37746045-52C4F9DF-2161-4590-B73D-9EF0086A8AF4 Q38239137-1ED3ECFF-CC54-4BF0-B494-22E25547B4DD Q38637968-4D3BEB7F-3D9E-4B8A-99AA-3FC78273A4E2 Q38722973-CA090C15-46C3-4FF9-B82B-E4BACF20E424 Q38727627-E24EEF14-B00E-4DE2-AF13-48A9389C734A Q38733504-EB76E88B-8C38-48FA-B6FD-C6FEEC7D0790 Q38794065-97C0BF2B-5597-4C13-A787-0C75237CCB9F Q38845654-94C3233A-3EE2-442A-A669-A469A406BE8A Q38866185-61EC9577-3E1D-476A-AB23-6317C4CCE65D

P2860

Sox2 promotes tamoxifen resistance in breast cancer cells.

http://www.wikidata.org/entity/Q34381786

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Sox2 promotes tamoxifen resistance in breast cancer cells.

@ast

Sox2 promotes tamoxifen resistance in breast cancer cells.

@en

Sox2 promotes tamoxifen resistance in breast cancer cells.

@nl

type

label

Sox2 promotes tamoxifen resistance in breast cancer cells.

@ast

Sox2 promotes tamoxifen resistance in breast cancer cells.

@en

Sox2 promotes tamoxifen resistance in breast cancer cells.

@nl

prefLabel

Sox2 promotes tamoxifen resistance in breast cancer cells.

@ast

Sox2 promotes tamoxifen resistance in breast cancer cells.

@en

Sox2 promotes tamoxifen resistance in breast cancer cells.

@nl

P1433

Q34381786-EE009260-B2B7-42C9-860F-EEDCF6C4970B

P1476

Q34381786-F05E522D-DD69-404B-9D5C-F67FC5130B88

P2093

Q34381786-052AD7A6-4006-464C-858B-DE7C69E75520

Q34381786-463B405A-41F9-42FA-99D1-8CC5B3B48912

Q34381786-569959B0-04E4-461D-8B94-9EC791E5E84E

Q34381786-5B2F7DA0-EEAA-4D59-B571-201D1F5B7BC8

Q34381786-9FD60C94-DEA2-4998-9C04-1243E2AB9BB0

Q34381786-C709FF24-97BA-456F-BA25-C23A9A56CF9B

P2860

Q34381786-03DDEFE3-D3C7-4576-A67A-508647A29BC8

Q34381786-07FEEE82-C578-41D5-919A-D5DB0F8EFD80

Q34381786-08CDD833-632C-4E22-923E-A1F4226F6CA7

Q34381786-0C3BE315-166E-4647-9FCC-EED709768FF2

Q34381786-0E76D3B9-3CE7-400C-9A12-05C8AB703256

Q34381786-116A5A7F-66AD-474D-ABD7-B5910551FC82

Q34381786-238F99A9-2DC9-49E0-9DD7-B44C75BD02E8

Q34381786-35036F12-74E0-4D1E-9882-68826D3DDE75

Q34381786-3C16CFBD-F651-41C7-AD50-6D83C3DC4AA2

Q34381786-3CA34AC9-2DFD-4FA3-B095-C01604B68352

P304

Q34381786-43121E74-4410-4E68-9047-BCB34EE2DFE2

P31

Q34381786-B06F4716-72D0-4769-B92E-C653C6CD0A52

P356

Q34381786-502F71F8-6259-4AC0-8522-E4398DF4655A

P433

Q34381786-CE30BB5E-930E-41BC-8081-1E7FF83D5662

P478

Q34381786-A498E19B-21DE-403F-9CC8-5C60A87DFB58

P50

Q34381786-35DC8632-5176-46A0-B466-6659217DE1A9

Q34381786-59E5AB3E-DB35-4B73-8500-1C9F0D4F63A2

Q34381786-91115A17-F107-4196-A4A1-330D9C6F49A1

Q34381786-9FCE59EE-27D9-458D-BCF6-36BE92FDDFC8

Q34381786-A62F1AC5-1903-41D5-8927-A9FC00BF5521

P577

Q34381786-488CC9FB-1B9E-4DCF-A6AF-AE844575270E

P5875

Q34381786-7BF83BFD-09D4-4FDA-8CD2-54542F605B23

P698

Q34381786-A604B26B-1D44-47D2-ABF2-DF39BE5FB966

P932

Q34381786-F971EA29-7452-4CE6-AA16-E03C8B350BDD

P356

P1433

EMBO Molecular Medicine

P1476

Sox2 promotes tamoxifen resistance in breast cancer cells.

@en

P2093

Bruno M Simões

http://www.w3.org/2001/XMLSchema#string

Ignacio Zabalza

http://www.w3.org/2001/XMLSchema#string

Inmaculada Barredo

http://www.w3.org/2001/XMLSchema#string

Jose A López-Ruiz

http://www.w3.org/2001/XMLSchema#string

Miriam Rábano

http://www.w3.org/2001/XMLSchema#string

Oihana Iriondo

http://www.w3.org/2001/XMLSchema#string

P2860

Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism

The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer

A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Stem cells, cancer, and cancer stem cells

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer

P304

66-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201303411

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Valentine Comaills

Maria D. Vivanco

Giacomo Domenici

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258215402

http://www.w3.org/2001/XMLSchema#string

P698

24178749

http://www.w3.org/2001/XMLSchema#string

P932

3936493

http://www.w3.org/2001/XMLSchema#string